Clarivate stock gains on positive growth outlook from Stifel

Stifel reiterated a Buy rating and $5.00 price target for Clarivate (NYSE:CLVT) after its IP unit showed 1% organic growth and positive ACV growth. Clarivate expects 2% organic growth in Q4 2026 and 9-18% free cash flow growth in 2027. The stock rose 24% intraday. Q3 2026 earnings beat estimates at $0.21 per share, but revenue missed at $481.6M.

Original reporting
Published Nov 4, 2026, 3:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 3:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$CLVT
Bullish
high confidence
Mentioned
$CLVT
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CLVTBullishHigh
01

Why it matters

The analyst upgrade and price target provide a fresh catalyst that can justify the recent 24% price surge and may attract further buying.

02

Market read

A new buy rating with a specific price target on a mid‑cap data‑services company, coupled with a sizable intraday rally, offers a clear short‑term trading opportunity.

03

What to watch

Potential headwinds from the Life Sciences & Healthcare divestiture and broader market volatility.

Relevance 6/10Novelty 6/10Timing: intraday today

Background

Stifel analysts highlighted Clarivate's first ACV growth in three years and a $20 million AI‑enabled pipeline, projecting 2% organic growth in Q4 2026 and 9‑18% free‑cash‑flow growth in 2027.

Company-level read

Ticker impact

$CLVTBullishHigh confidence
Context

Stifel reiterated a Buy rating and set a $5.00 price target for Clarivate, citing organic growth and a positive 2027 outlook, which helped the stock jump 24% intraday.

Expected impact

upward pressure as investors price in the positive growth outlook and target

Evidence & confidence

Analyst endorsement with a concrete price target typically drives buying interest, especially after a large intraday rally.

Market effects

Positive outlook for Clarivate may lift other information‑services and data‑analytics stocks.

US equity markets could see modest gains in the tech/data sector.

Limited to investors tracking US-listed data and analytics firms.

Counterpoint

The revenue miss and ongoing portfolio reshaping could limit upside despite the buy rating.

Key entities

  • Clarivate Plc

    US‑listed data and analytics provider (NYSE:CLVT).

  • Stifel

    Equity research firm issuing the buy rating and price target.

Related articles

$CLVTMedAI 8/10

Clarivate Plc: Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Plc (NYSE: CLVT) announced the final results of its cash tender offers for certain outstanding debt securities. The company will purchase $415M of 3.875% Senior Secured Notes due 2028 and $118M of 4.875% Senior Notes due 2029, with proration factors of 67.9% and 45.5%, respectively. The offers expired on November 10, 2026, and settlements will occur on November 13, 2026.

$CLVTMedAI 8/10

Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, November 12, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration a

$CLVTHigh

Clarivate Plc: Clarivate Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Plc (NYSE: CLVT) announced pricing terms for its cash tender offers to purchase certain outstanding debt securities. The company is offering to buy back its 3.875% Senior Secured Notes due 2028 and 4.875% Senior Notes due 2029, with a total cap of $500 million. The 2028 Notes Total Consideration is based on a fixed spread and a reference yield, while the 2029 Notes will be purchased at $928.75 per $1,000 principal amount. The settlement date is expected to be November 13, 2026.